David Liew

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Fabien Vincent

MONASH UNIVERSITY

AUSTRALIA

View details

Alexandre Sepriano

Assistant Professor of Rheumatology

Nova Medical School

PORTUGAL

View details

Margreet Kloppenburg

Full Professor

Leiden University Medical Center

NETHERLANDS

View details

Catherine Hill

University of Adelaide

AUSTRALIA

View details

Tue Wenzel Kragstrup

Aarhus University

DENMARK

View details

Susanna Proudman

AUSTRALIA

View details

Philip C. Robinson

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Liew

Research Interests

Explore related searches

Contact this professor

Articles (19)

Treat-to-target in polymyalgia rheumatica and giant cell arteritis: an impending, multifaceted challenge

Subclinical giant cell arteritis in polymyalgia rheumatica: is vascular imaging really ready to determine steroid dosing?

A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a “Safety Checklist”

Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care.

Clinical evaluation is critical for the implementation of artificial intelligence in health care: comment on the article by Mickley et al

Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica.

The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review.

Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights.

Impact of the COVID‐19 Pandemic on Healthcare Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients with Systemic Sclerosis

JAK inhibitors and black box warnings: what is the future for JAK inhibitors?

Medicines stewardship

Design and implementation of an electronic opioid management plan to support consistent communication of opioid analgesia prescribing intentions to patients and general practitioners

Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors

Should race be considered in diagnosing giant cell arteritis? – Authors' reply

Imaging of giant cell arteritis - recent advances.

Giant cell arteritis can occur in people of colour

Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culture

Better diagnostic tools needed for biopsy-negative giant cell arteritis

Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas

Collaborators (7)

Fabien Vincent

Alexandre Sepriano

Margreet Kloppenburg

Catherine Hill

Tue Wenzel Kragstrup

Susanna Proudman

Philip C. Robinson

Make your next move.